288 related articles for article (PubMed ID: 30804356)
1. Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa.
Drain PK; Hong T; Krows M; Govere S; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Bassett IV; Celum C
Sci Rep; 2019 Feb; 9(1):2687. PubMed ID: 30804356
[TBL] [Abstract][Full Text] [Related]
2. Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
Drain PK; Galagan SR; Govere S; Krows M; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Celum C; Bassett IV
J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1205-1213. PubMed ID: 33990495
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease.
Boyd K; Kouamou V; Hlupeni A; Tangwena Z; Ndhlovu CE; Makadzange AT;
Microbiol Spectr; 2022 Aug; 10(4):e0107522. PubMed ID: 35924841
[TBL] [Abstract][Full Text] [Related]
4. Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center.
Vidal JE; Toniolo C; Paulino A; Colombo AL; Martins MDA; Meira CDS; Azevedo RGS; Pereira-Chioccola VL; Gomes HR; Lazera MDS; Oliveira ACP; Boulware DR
Rev Inst Med Trop Sao Paulo; 2018; 60():e1. PubMed ID: 29451598
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immunomycologics Lateral Flow Assay.
Wake RM; Jarvis JN; Harrison TS; Govender NP
J Acquir Immune Defic Syndr; 2018 Aug; 78(5):574-578. PubMed ID: 29771787
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.
Williams DA; Kiiza T; Kwizera R; Kiggundu R; Velamakanni S; Meya DB; Rhein J; Boulware DR
Clin Infect Dis; 2015 Aug; 61(3):464-7. PubMed ID: 25838287
[TBL] [Abstract][Full Text] [Related]
10. LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY.
Vidal JE; Boulware DR
Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):38-45. PubMed ID: 26465368
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV Disease.
Jarvis JN; Tenforde MW; Lechiile K; Milton T; Boose A; Leeme TB; Tawe L; Muthoga C; Rukasha I; Mulenga F; Rulaganyang I; Molefi M; Molloy SF; Ngidi J; Harrison TS; Govender NP; Mine M
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32461286
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal Antigenemia.
Skipper C; Tadeo K; Martyn E; Nalintya E; Rajasingham R; Meya DB; Kafufu B; Rhein J; Boulware DR
J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 32024729
[TBL] [Abstract][Full Text] [Related]
13. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.
Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR
Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease.
Tenforde MW; Boyer-Chammard T; Muthoga C; Tawe L; Milton T; Rulaganyang I; Lechiile K; Rukasha I; Leeme TB; Govender NP; Ngidi J; Mine M; Molloy SF; Harrison TS; Lortholary O; Jarvis JN
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087436
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency department.
Oliveira FG; Nakagawa JAS; de Oliveira JMM; Júnior RML; Marcusso R; Vidal JE
Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37656871
[TBL] [Abstract][Full Text] [Related]
16. Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho.
Rick F; Niyibizi AA; Shroufi A; Onami K; Steele SJ; Kuleile M; Muleya I; Chiller T; Walker T; Van Cutsem G
PLoS One; 2017; 12(9):e0183656. PubMed ID: 28877182
[TBL] [Abstract][Full Text] [Related]
17. The incidence of histoplasmosis and cryptococcal antigenemia among patients attending a large HIV clinic in Trinidad.
Edwards RJ; Todd S; Edwards J; Samaroo-Francis W; Lyons N; Boyce G; Denning DW
Diagn Microbiol Infect Dis; 2023 Aug; 106(4):115952. PubMed ID: 37267742
[TBL] [Abstract][Full Text] [Related]
18. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast.
Boulware DR; Rolfes MA; Rajasingham R; von Hohenberg M; Qin Z; Taseera K; Schutz C; Kwizera R; Butler EK; Meintjes G; Muzoora C; Bischof JC; Meya DB
Emerg Infect Dis; 2014 Jan; 20(1):45-53. PubMed ID: 24378231
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
Coetzee LM; Cassim N; Sriruttan C; Mhlanga M; Govender NP; Glencross DK
PLoS One; 2018; 13(6):e0198993. PubMed ID: 29894509
[TBL] [Abstract][Full Text] [Related]
20. Serum Cryptococcal Antigen Testing in Immunosuppressed HIV-positive Children and Adolescents.
Zuma P; Ramsamy Y; Mlisana K; Archary M
Pediatr Infect Dis J; 2020 Mar; 39(3):217-220. PubMed ID: 31725553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
